251 related articles for article (PubMed ID: 15809436)
21. Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap 'n' collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2): cross-interaction between AhR (aryl hydrocarbon receptor) and Nrf2 signal transduction.
Ma Q; Kinneer K; Bi Y; Chan JY; Kan YW
Biochem J; 2004 Jan; 377(Pt 1):205-13. PubMed ID: 14510636
[TBL] [Abstract][Full Text] [Related]
22. beta-Lapachone-induced apoptosis in human prostate cancer cells: involvement of NQO1/xip3.
Planchon SM; Pink JJ; Tagliarino C; Bornmann WG; Varnes ME; Boothman DA
Exp Cell Res; 2001 Jul; 267(1):95-106. PubMed ID: 11412042
[TBL] [Abstract][Full Text] [Related]
23. Turmeric toxicity in A431 epidermoid cancer cells associates with autophagy degradation of anti-apoptotic and anti-autophagic p53 mutant.
Thongrakard V; Titone R; Follo C; Morani F; Suksamrarn A; Tencomnao T; Isidoro C
Phytother Res; 2014 Dec; 28(12):1761-9. PubMed ID: 25044209
[TBL] [Abstract][Full Text] [Related]
24. Disruption of the NAD(P)H:quinone oxidoreductase 1 (NQO1) gene in mice causes myelogenous hyperplasia.
Long DJ; Gaikwad A; Multani A; Pathak S; Montgomery CA; Gonzalez FJ; Jaiswal AK
Cancer Res; 2002 Jun; 62(11):3030-6. PubMed ID: 12036909
[TBL] [Abstract][Full Text] [Related]
25. Mutant p53R273H attenuates the expression of phase 2 detoxifying enzymes and promotes the survival of cells with high levels of reactive oxygen species.
Kalo E; Kogan-Sakin I; Solomon H; Bar-Nathan E; Shay M; Shetzer Y; Dekel E; Goldfinger N; Buganim Y; Stambolsky P; Goldstein I; Madar S; Rotter V
J Cell Sci; 2012 Nov; 125(Pt 22):5578-86. PubMed ID: 22899716
[TBL] [Abstract][Full Text] [Related]
26. NAD(P)H quinone oxidoreductase protects TAp63gamma from proteasomal degradation and regulates TAp63gamma-dependent growth arrest.
Hershkovitz Rokah O; Shpilberg O; Granot G
PLoS One; 2010 Jun; 5(6):e11401. PubMed ID: 20613985
[TBL] [Abstract][Full Text] [Related]
27. Role of NAD(P)H:quinone oxidoreductase in the progression of neuronal cell death in vitro and following cerebral ischaemia in vivo.
Kapinya KJ; Harms U; Harms C; Blei K; Katchanov J; Dirnagl U; Hörtnagl H
J Neurochem; 2003 Mar; 84(5):1028-39. PubMed ID: 12603827
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxicity of RH1: NAD(P)H:quinone acceptor oxidoreductase (NQO1)-independent oxidative stress and apoptosis induction.
Tudor G; Alley M; Nelson CM; Huang R; Covell DG; Gutierrez P; Sausville EA
Anticancer Drugs; 2005 Apr; 16(4):381-91. PubMed ID: 15746574
[TBL] [Abstract][Full Text] [Related]
29. Suppression of NAD(P)H-quinone oxidoreductase 1 enhanced the susceptibility of cholangiocarcinoma cells to chemotherapeutic agents.
Zeekpudsa P; Kukongviriyapan V; Senggunprai L; Sripa B; Prawan A
J Exp Clin Cancer Res; 2014 Jan; 33(1):11. PubMed ID: 24460787
[TBL] [Abstract][Full Text] [Related]
30. Development of indolequinone mechanism-based inhibitors of NAD(P)H:quinone oxidoreductase 1 (NQO1): NQO1 inhibition and growth inhibitory activity in human pancreatic MIA PaCa-2 cancer cells.
Reigan P; Colucci MA; Siegel D; Chilloux A; Moody CJ; Ross D
Biochemistry; 2007 May; 46(20):5941-50. PubMed ID: 17455910
[TBL] [Abstract][Full Text] [Related]
31. Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H:quinone oxidoreductase 1: role of 17-AAG hydroquinone in heat shock protein 90 inhibition.
Guo W; Reigan P; Siegel D; Zirrolli J; Gustafson D; Ross D
Cancer Res; 2005 Nov; 65(21):10006-15. PubMed ID: 16267026
[TBL] [Abstract][Full Text] [Related]
32. NADPH quinone oxidoreductase 1 mediates breast cancer cell resistance to thymoquinone-induced apoptosis.
Sutton KM; Doucette CD; Hoskin DW
Biochem Biophys Res Commun; 2012 Sep; 426(3):421-6. PubMed ID: 22960073
[TBL] [Abstract][Full Text] [Related]
33. NQO1: A target for the treatment of cancer and neurological diseases, and a model to understand loss of function disease mechanisms.
Beaver SK; Mesa-Torres N; Pey AL; Timson DJ
Biochim Biophys Acta Proteins Proteom; 2019; 1867(7-8):663-676. PubMed ID: 31091472
[TBL] [Abstract][Full Text] [Related]
34. Irradiation-induced p53 expression is attenuated in cells with NQO1 C465T polymorphism.
Sato M; Takagi M; Mizutani S
J Med Dent Sci; 2010 Jun; 57(2):139-45. PubMed ID: 21073132
[TBL] [Abstract][Full Text] [Related]
35. Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to radiation-induced myeloproliferative disease.
Iskander K; Barrios RJ; Jaiswal AK
Cancer Res; 2008 Oct; 68(19):7915-22. PubMed ID: 18829548
[TBL] [Abstract][Full Text] [Related]
36. Interaction of human NAD(P)H:quinone oxidoreductase 1 (NQO1) with the tumor suppressor protein p53 in cells and cell-free systems.
Anwar A; Dehn D; Siegel D; Kepa JK; Tang LJ; Pietenpol JA; Ross D
J Biol Chem; 2003 Mar; 278(12):10368-73. PubMed ID: 12529318
[TBL] [Abstract][Full Text] [Related]
37. Protection of hydroquinone-induced apoptosis by downregulation of Fau is mediated by NQO1.
Siew EL; Chan KM; Williams GT; Ross D; Inayat-Hussain SH
Free Radic Biol Med; 2012 Oct; 53(8):1616-24. PubMed ID: 22687461
[TBL] [Abstract][Full Text] [Related]
38. Role of NAD(P)H:quinone oxidoreductase (NQO1) in apoptosis induction by aziridinylbenzoquinones RH1 and MeDZQ.
Nemeikaite-Ceniene A; Dringeliene A; Sarlauskas J; Cenas N
Acta Biochim Pol; 2005; 52(4):937-41. PubMed ID: 15940348
[TBL] [Abstract][Full Text] [Related]
39. Evidence for NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated quinone-dependent redox cycling via plasma membrane electron transport: A sensitive cellular assay for NQO1.
Tan AS; Berridge MV
Free Radic Biol Med; 2010 Feb; 48(3):421-9. PubMed ID: 19932748
[TBL] [Abstract][Full Text] [Related]
40. p53 proteasomal degradation: poly-ubiquitination is not the whole story.
Asher G; Shaul Y
Cell Cycle; 2005 Aug; 4(8):1015-8. PubMed ID: 16082197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
